COMMUNIQUÉS West-GlobeNewswire

Ori Biotech and Charles River Laboratories Collaborate to Accelerate Life-Saving Cell and Gene Therapy Development and Manufacturing

18/09/2024 - 14:30

New Biological Data Released from IRO® Cell Therapy Manufacturing Platform PHILADELPHIA, Sept. 18, 2024 (GLOBE NEWSWIRE) -- Ori Biotech (Ori), a leader in cell and gene therapy (CGT) manufacturing enabling technology, [...]

Femasys Announces Infertility Clinic Customers from Coast to Coast

18/09/2024 - 14:30

Leading medical clinics become key regional resources to offer FemaSeed infertility treatment ATLANTA, Sept. 18, 2024 (GLOBE NEWSWIRE) -- Femasys, Inc., (Nasdaq: FEMY), a leading biomedical company focused on addressing [...]

BioCardia Regains Full Compliance with Nasdaq Listing Requirements

18/09/2024 - 14:30

SUNNYVALE, Calif., Sept. 18, 2024 (GLOBE NEWSWIRE) -- BioCardia, Inc. [Nasdaq: BCDA], a global leader in cellular and cell-derived therapeutics for the treatment of cardiovascular and pulmonary diseases, announced today [...]

Vaccinex Announces Exercise of Warrants for $6.2 Million in Gross Proceeds

18/09/2024 - 14:30

ROCHESTER, N.Y., Sept. 18, 2024 (GLOBE NEWSWIRE) -- Vaccinex, Inc. (Nasdaq: VCNX) (“Vaccinex” or the “Company”), a clinical-stage biotechnology company pioneering a differentiated approach to treating neurodegenerative [...]

Procaps Issues Shareholder Letter Update

18/09/2024 - 14:10

MIAMI and BARRANQUILLA, Colombia, Sept. 18, 2024 (GLOBE NEWSWIRE) -- Procaps Group, S.A. (NASDAQ: PROC) (“Procaps” or the “Company”), a leading integrated LatAm healthcare and pharmaceutical services, today issued the [...]

Kairos Pharma Closing of $6.2 Million Initial Public Offering

17/09/2024 - 22:29

LOS ANGELES, Sept. 17, 2024 (GLOBE NEWSWIRE) -- Kairos Pharma, Ltd. (“Kairos Pharma” or the “Company”) (NYSE American: KAPA), a clinical stage biopharmaceutical company developing cancer therapeutics designed to reverse [...]

Independent Directors of 23andMe Resign from Board

17/09/2024 - 22:26

SOUTH SAN FRANCISCO, Calif., Sept. 17, 2024 (GLOBE NEWSWIRE) -- The independent directors of the Board of 23andMe Holding Co. (Nasdaq: ME), today sent the following letter to Anne Wojcicki, Chief Executive Officer, Co- [...]

Traws Pharma, Inc. Announces Special Shareholders Meeting Results

17/09/2024 - 22:05

Three proposals, including a reverse stock split, were submitted and approved Traws Board subsequently approved a 1-for-25 reverse stock split Traws’ shares expected to begin trading on a split-adjusted basis on [...]

Jushi Holdings Inc. Announces Options Issued to Executive Officers

17/09/2024 - 22:05

BOCA RATON, Fla., Sept. 17, 2024 (GLOBE NEWSWIRE) -- Jushi Holdings Inc. (“Jushi” or the “Company”) (CSE: JUSH ) ( OTCQX: JUSHF ), a vertically integrated, multi-state cannabis operator, is pleased to announce that [...]

RadNet, Inc. to Present at the Sidoti & Company Small Cap 2024 Virtual Conference on Wednesday, September 18th

17/09/2024 - 22:05

LOS ANGELES, Sept. 17, 2024 (GLOBE NEWSWIRE) -- RadNet, Inc. (NASDAQ: RDNT ), a national leader in providing high-quality, cost-effective diagnostic imaging services through a network of fully-owned and operated [...]

Structure Therapeutics Strengthens Executive Team with Promotion of Blai Coll, M.D., Ph.D. to Chief Medical Officer and Appointment of Ashley Hall, J.D. as Chief Development Officer

17/09/2024 - 22:05

SAN FRANCISCO, Sept. 17, 2024 (GLOBE NEWSWIRE) -- Structure Therapeutics Inc. (NASDAQ: GPCR), a clinical-stage global biopharmaceutical company developing novel oral small molecule therapeutics for metabolic and [...]

Fairway Consulting Group Appoints Brennan Clark as Vice President of Executive Search

17/09/2024 - 19:25

NEW YORK, Sept. 17, 2024 (GLOBE NEWSWIRE) -- Fairway Consulting Group (FCG) , a leading executive search firm focused on providing outstanding talent solutions for the pharmaceutical, biotechnology, diagnostic, and [...]

Move Health Holdings Corp. and No Fear Counselling Corp. Complete Merger Transaction

17/09/2024 - 19:19

VANCOUVER, British Columbia and TORONTO, Sept. 17, 2024 (GLOBE NEWSWIRE) -- Move Health Holdings Corp . (“Move Health”) and No Fear Counselling Corp . (“No Fear Counselling”), two of Canada’s foremost health and [...]

Inteleos Donates 49 Laptops to Annapolis Trust, Empowering Disadvantaged Students with Technology Skills

17/09/2024 - 19:03

ROCKVILLE, Md., Sept. 17, 2024 (GLOBE NEWSWIRE) -- Inteleos, a global nonprofit healthcare certification organization, is proud to announce the donation of 49 laptops to the Annapolis Trust , a nonprofit organization [...]

FDA approves Novartis Kisqali® to reduce risk of recurrence in people with HR+/HER2- early breast cancer

17/09/2024 - 18:55

Ad hoc announcement pursuant to Art. 53 LR Broad indication in HR+/HER2- stage II and III early breast cancer (EBC) at high risk of recurrence approximately doubles population eligible for CDK4/6 inhibitor adjuvant [...]

EssilorLuxottica unveils plans for its new corporate headquarters in Paris

17/09/2024 - 18:45

EssilorLuxottica unveils plans for its new corporate headquarters in Paris Paris, France (September 17, 2024) – EssilorLuxottica announced today the signing of a long-term pre-letting agreement for its new global [...]

EssilorLuxottica dévoile son futur siège social à Paris

17/09/2024 - 18:45

EssilorLuxottica dévoile son futur siège social à Paris Paris, France (17septembre 2024) – EssilorLuxottica annonce la signature d'un bail de long-terme pour l’installation de son nouveau siège mondial à Paris, à [...]

EssilorLuxottica: Déclaration de transactions sur actions propres

17/09/2024 - 18:00

Déclaration de transactions sur actions propres Paris, France (17 septembre 2024, 18h00) – Conformément à l’autorisation octroyée par l’Assemblée Générale du 30 avril 2024, EssilorLuxottica déclare que du 10 septembre [...]

Idorsia continues to further the science of sleep and insomnia with new daridorexant data and analyses published at Sleep Europe 2024

17/09/2024 - 17:45

Allschwil, Switzerland – September 17, 2024 Idorsia Ltd (SIX: IDIA) today announced that new data and analyses of daridorexant, Idorsia’s dual orexin receptor antagonist for the treatment of adults with chronic insomnia [...]